Year : 2023
Voyage of Measurable Residual Disease (MRD) Assessment in Multiple Myeloma Using Multiparametric Flow Cytometry
Cite this Research Publication : Das N & Gupta R. (2023). Voyage of Measurable Residual Disease (MRD) Assessment in Multiple Myeloma Using Multiparametric Flow Cytometry. Indian Journal of Medical and Paediatric Oncology. 10.1055/s-0043-1768176
Publisher : Indian Journal of Medical and Paediatric Oncology
Year : 2023
Graded Depth of Response and Neoplastic Plasma Cell Index as Indicators of Survival Outcomes in Patients With Multiple Myeloma Following Autologous Stem Cell Transplant
Cite this Research Publication : Das N, Dahiya M, Gupta R, Kumar L, Rani L, Gupta A, Farswan A, Sharma A, Sharma OD. Graded Depth of Response and Neoplastic Plasma Cell Index as Indicators of Survival Outcomes in Patients With Multiple Myeloma Following Autologous Stem Cell Transplant. Am J Clin Pathol. 2023 Jan 4; 159(1):69-80. doi: 10.1093/ajcp/aqac129. PMID: 36317501
Publisher : Am J Clin Pathol.
Year : 2023
The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study from a Tertiary Care Hospital in India
Cite this Research Publication : Dwivedi T, Raj A, Das N, Gupta R, Gupta N, Tiwari P, Sahoo B, Sagiraju H K R, Sirohiya P, Ratre B, Elavarasi A, Mohan A & Bhatnagar S. (2023). The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study from a Tertiary Care Hospital in India. Cureus. 10.7759/cureus.40273
Publisher : Cureus
Year : 2022
Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous? -A retrospective cohort study
Cite this Research Publication : Sirohiya P, Elavarasi A, Sagiraju HKR, Baruah M, Gupta N, Garg RK, Paul SS, Ratre BK, Singh R, Kumar B, Vig S, Pandit A, Kumar A, Garg R, Meena VP, Mittal S, Pahuja S, Das N, Dwivedi T, Gupta R, Kumar S, Pandey M, Mishra A, Matharoo KS, Mohan A, Guleria R, Bhatnagar S. Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous? -A retrospective cohort study. Lung India. 2022 May-Jun; 39(3):247-253. doi: 10.4103/lungindia.lungindia_601_21. PMID: 35488682; PMCID: PMC9200195
Publisher : Lung India
Year : 2022
Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with patternbased recognition
Cite this Research Publication : Das N, Dahiya M, Gupta R, Rai S, Singh S, Prajapati VK, Kumar L, Sharma A, Sahoo RK, Gogia A. Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with patternbased recognition. Cytometry B Clin Cytom. 2022 Jul; 102(4):292-302. doi: 10.1002/cyto.b.22062. Epub 2022 Feb 25. PMID: 35212134
Publisher : Cytometry B Clin Cytom
Year : 2022
Effect of the sequence of pull of bone marrow aspirates on plasma cell quantification in plasma cell proliferative disorders
Cite this Research Publication : Jain G, Das N, Gajendra S, et al. Effect of the sequence of pull of bone marrow aspirates on plasma cell quantification in plasma cell proliferative disorders. Int J Lab Hematol. 2022; 1- 9. doi:10.1111/ijlh.13887
Publisher : Int J Lab Hematol
Year : 2022
Genomic landscape of mature B-cell non-Hodgkin lymphomas – An appraisal from lymphomagenesis to drug resistance
Cite this Research Publication : Panda D, Das N, Thakral D, Gupta R. Genomic landscape of mature B-cell non-Hodgkin lymphomas - An appraisal from lymphomagenesis to drug resistance. Journal of the Egyptian National Cancer Institute. 2022- Accepted
Publisher : Journal of the Egyptian National Cancer Institute
Year : 2022
Relevance of polyclonal plasma cells and post-therapy immunomodulation in measurable residual disease assessment in multiple myeloma
Cite this Research Publication : Das N, Dahiya M, Gupta R, Kumar L, Sharma A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A. Relevance of polyclonal plasma cells and post-therapy immunomodulation in measurable residual disease assessment in multiple myeloma. Cytometry B Clin Cytom. 2022 May; 102(3):209-219. doi: 10.1002/cyto.b.22068. Epub 2022 Apr 7. PMID: 35389550
Publisher : Cytometry B Clin Cytom
Year : 2022
Utility of CD229 as novel marker in measurable residual disease assessment in Multiple Myeloma – an evidence-based approach
Cite this Research Publication : Rai S*, Das N*, Gupta R, Kumar L, Sharma A, Singh S, Prajapati VK. Utility of CD229 as novel marker in measurable residual disease assessment in Multiple Myeloma - an evidence-based approach. Int J Lab Hematol. 2022- Accepted
Publisher : Int J Lab Hematol
Year : 2021
The effectiveness of SARS-CoV-2 vaccination in preventing severe illness and death – real-world data from a cohort of patients hospitalized with COVID-19
Cite this Research Publication : Sagiraju H R, Elavarasi A, Gupta N, Kumar R, Paul S S, Vig S, Sirohiya P & Ratre B, Garg R, Pandit A, Singh R, Kumar B, Meena V, Wig N, Mittal S, Pahuja S, Madan K, Das N, Dwivedi T, Bhatnagar S. The effectiveness of SARS-CoV-2 vaccination in preventing severe illness and death – real-world data from a cohort of patients hospitalized with COVID-19. medRxiv 2021.08.26.21262705
Publisher : medRxiv
Year : 2021
Evaluation of Immunophenotype of the Non-Neoplastic Plasma Cell Compartment and Post-Therapy Immunomodulation to Understand Nuances in MRD Assessment of Multiple Myeloma Using Next-Generation Flow Cytometry
Cite this Research Publication : Gupta R, Das N, Dahiya M, Rai S, Singh S, Prajapati V, Sahoo R, Gogia A, Sharma A, Kumar L. Evaluation of Immunophenotype of the Non-Neoplastic Plasma Cell Compartment and Post-Therapy Immunomodulation to Understand Nuances in MRD Assessment of Multiple Myeloma Using Next-Generation Flow Cytometry. Clin Lymphoma Myeloma Leuk. 2021; 21. S436- S437
Publisher : Clin Lymphoma Myeloma Leuk
Year : 2021
Pattern-Based Identification of Normal and Aberrant Plasma Cell Compartment across a Spectrum of Plasma Cell Proliferative Disorders Using Multiparametric Flow Cytometry.
Cite this Research Publication : Das N, Gupta R, Dahiya M, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A, Sharma A, Kumar L. Pattern-Based Identification of Normal and Aberrant Plasma Cell Compartment across a Spectrum of Plasma Cell Proliferative Disorders Using Multiparametric Flow Cytometry. Clin Lymphoma Myeloma Leuk. 2021; 21(1): S438. ISSN 2152-2650
Publisher : Clin Lymphoma Myeloma Leuk
Year : 2021
Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL
Cite this Research Publication : Das N, Gupta R, Gupta SK, Bakhshi S, Seth R, Kumar C, Rai S, Singh S, Prajapati VK, Gogia A, Sahoo RK, Sharma A, Kumar L. Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL. Ann Hematol. 2021 Oct; 100(10):2487-2500. doi: 10.1007/s00277-021-04580-2. Epub 2021 Jul 8. PMID: 34236495
Publisher : Ann Hematol
Year : 2020
A Realworld Perspective of CD123 Expression in Acute Leukemia as Promising Biomarker to Predict Treatment Outcome in B-ALL and AML
Cite this Research Publication : Das N, Gupta R, Gupta SK, Bakhshi S, Malhotra A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A, Sharma A, Kumar L. A Realworld Perspective of CD123 Expression in Acute Leukemia as Promising Biomarker to Predict Treatment Outcome in B-ALL and AML. Clin Lymphoma Myeloma Leuk. 2020 Oct; 20(10): e673-e684. doi: 10.1016/j.clml.2020.05.004. Epub 2020 May 11. PMID: 32561191
Publisher : Clin Lymphoma Myeloma Leuk
Year : 2020
Cell-free DNA for genomic profiling and minimal residual disease monitoring in Myeloma- are we there yet?
Cite this Research Publication : Thakral D*, Das N*, Basnal A, Gupta R. Cell-free DNA for genomic profiling and minimal residual disease monitoring in Myeloma- are we there yet? Am J Blood Res. 2020 Jun 15; 10(3):26-45. PMID: 32685257; PMCID: PMC7364270
Publisher : Am J Blood Res
Year : 2019
To explore the utility of diagnostic immunophenotypes for detection of MRD in B ALL
Cite this Research Publication : Das N, Gupta Ritu, Malhotra Ankit, Rai Sandeep, Gupta Sanjeev, Singh Saroj, Sahoo Ranjit, Gogia Ajay, Bakhshi Sameer, Kumar Lalit. To explore the utility of diagnostic immunophenotypes for detection of MRD in B ALL - Indian Journal of Hematol and Blood Transfusion (2019) 35: S26
Publisher : Indian Journal of Hematol and Blood Transfusion
Year : 2019
Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia
Cite this Research Publication : Das N, Malhotra Ankit, Gupta Ritu, Rai Sandeep, Gupta Sanjeev, Singh Saroj, Sahoo Ranjit, Gogia Ajay, Bakhshi Sameer, Kumar Lalit. (2019). Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 19. S235. https://doi.org/10.1016/j.clml.2019.07.123
Publisher : Clin Lymphoma Myeloma Leuk.
Year : 2019
CD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia
Cite this Research Publication : Das N, Malhotra A, Gupta Ritu, Rai Sandeep, Gupta Sanjeev, Sahoo Ranjit, Gogia Ajay, Bakhshi Sameer, Kumar Lalit, Singh Saroj. (2019). CD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. 19. S197
Publisher : Clin Lymphoma Myeloma Leuk
Year : 2019
FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor
Cite this Research Publication : Das N, Thakral D, Singh G, Malhotra A, Phulware RH, Gogia A, Gupta R. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor. Indian J Pathol Microbiol. 2019 Oct-Dec;62(4):614-617. doi: 10.4103/IJPM.IJPM_520_18. PMID: 31611454
Publisher : Indian J Pathol Microbiol